moderate - Defense revenue (majority of business) is counter-cyclical or acyclical, driven by geopolitical factors and multi-year budget cycles rather than GDP. However, industrial end markets (automation, medical devices) are pro-cyclical and sensitive to capital equipment spending. Current revenue decline may reflect destocking in industrial channels. Net sensitivity is moderate given defense buffer against recession but industrial exposure to manufacturing activity.

Moderate impact through multiple channels. Rising rates increase financing costs for working capital (component inventory, receivables) though current debt/equity of 0.73 is manageable. More significantly, higher rates pressure industrial customers' capital budgets and delay equipment purchases. Defense spending is relatively rate-insensitive. Valuation multiples (EV/EBITDA 18.2x) are elevated for current margins, making the stock vulnerable to multiple compression if rates rise further and growth doesn't materialize.

momentum - The 144% one-year return despite deteriorating fundamentals (revenue -8.4%, earnings -45%) indicates momentum-driven buying, likely on defense spending themes or M&A speculation. Current valuation (EV/EBITDA 18.2x, P/S 2.1x) is elevated relative to 5.7% operating margins, suggesting growth expectations are priced in. Value investors would likely avoid given negative earnings growth and uncertain cash generation. Small-cap defense exposure attracts thematic investors betting on geopolitical tensions and budget increases.